Skip to main content
Top
Published in: BMC Geriatrics 1/2018

Open Access 01-12-2018 | Research article

Use of over the counter products in older cardiovascular patients admitted to a tertiary care center in USA

Authors: Marwan Sheikh-Taha, Hani Dimassi

Published in: BMC Geriatrics | Issue 1/2018

Login to get access

Abstract

Background

In recent years there has been a substantial increase in the use of over-the-counter (OTC) products around the world. While they are assumed to be safe by consumers, they can potentially lead to adverse effects and drug interactions particularly in older adults.

Methods

We assessed the patterns of OTC products used by older adults admitted to the cardiology service in a tertiary care medical center in the USA over a three month period. We conducted a retrospective chart review where older adults with cardiovascular diseases (CVD) who were taking at least one OTC product at home were included.

Results

Out of 404 patients who were admitted to the cardiology service, 281 (69.6%) were taking OTC products. Patients were taking a total of 659 OTC products; mean of 2.35 ± 1.57 and the range varied from 1 to 9 products. The most commonly used products were vitamins (37.3%), followed by laxatives (17%), minerals (13.6%), stomach acid reducers (9%), and analgesics (3.6%). OTC users were found to be suffering from more comorbidities and received more prescription medications as compared to non-users. Gender and age did not have an impact on the use of OTC products while patients with atrial fibrillation, sleep apnea and gastro-esophageal reflux disease were more likely to use OTC products.

Conclusion

Use of OTC products is quite frequent in older adults with CVD in our study. Clinicians should ask about OTC product usage and counsel patients about the risks and benefits associated with their use.
Literature
1.
go back to reference Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603.CrossRefPubMedPubMedCentral Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603.CrossRefPubMedPubMedCentral
2.
go back to reference de Souza Silva JE, Souza CA, da Silva TB, Gomes IA, de Carvalho Brito G, de Souza Araújo AA. de Lyra-Júnior DP, da Silva WB, da Silva FA. Use of herbal medicines by elderly patients: a systematic review. Arch Gerontol Geriatr. 2014;59(2):227–33.CrossRefPubMed de Souza Silva JE, Souza CA, da Silva TB, Gomes IA, de Carvalho Brito G, de Souza Araújo AA. de Lyra-Júnior DP, da Silva WB, da Silva FA. Use of herbal medicines by elderly patients: a systematic review. Arch Gerontol Geriatr. 2014;59(2):227–33.CrossRefPubMed
3.
go back to reference Artz MB, Harnack LJ, Duval SJ, Armstrong C, Arnett DK, Luepker RV. Use of nonprescription medications for perceived cardiovascular health. Am J Prev Med. 2006;30(1):78–81.CrossRefPubMed Artz MB, Harnack LJ, Duval SJ, Armstrong C, Arnett DK, Luepker RV. Use of nonprescription medications for perceived cardiovascular health. Am J Prev Med. 2006;30(1):78–81.CrossRefPubMed
4.
go back to reference Açıkgöz SK, Açıkgöz E, Topal S, Okuyan H, Yaman B, Er O, Şensoy B, Balcı MM, Aydoğdu S. Effect of herbal medicine use on medication adherence of cardiology patients. Complement Ther Med. 2014;22(4):648–54.CrossRefPubMed Açıkgöz SK, Açıkgöz E, Topal S, Okuyan H, Yaman B, Er O, Şensoy B, Balcı MM, Aydoğdu S. Effect of herbal medicine use on medication adherence of cardiology patients. Complement Ther Med. 2014;22(4):648–54.CrossRefPubMed
5.
go back to reference Krasuski RA, Michaelis K, Eckart RE. The cardiovascular patient's perceptions of complementary and alternative medicine. Clin Cardiol. 2006;29(4):161–4.CrossRefPubMedPubMedCentral Krasuski RA, Michaelis K, Eckart RE. The cardiovascular patient's perceptions of complementary and alternative medicine. Clin Cardiol. 2006;29(4):161–4.CrossRefPubMedPubMedCentral
6.
go back to reference Albert NM, Rathman L, Ross D, Walker D, Bena J, McIntyre S, Philip D, Siedlecki S, Lovelace R, Fogarty AM, Maikut B. Predictors of over-the-counter drug and herbal therapies use in elderly patients with heart failure. J Card Fail. 2009;15(7):600–6.CrossRefPubMed Albert NM, Rathman L, Ross D, Walker D, Bena J, McIntyre S, Philip D, Siedlecki S, Lovelace R, Fogarty AM, Maikut B. Predictors of over-the-counter drug and herbal therapies use in elderly patients with heart failure. J Card Fail. 2009;15(7):600–6.CrossRefPubMed
7.
go back to reference Pharand C, Ackman ML, Jackevicius CA, Paradiso-Hardy FL, Pearson GJ. Use of OTC and herbal products in patients with cardiovascular disease. Ann Pharmacother. 2003;37(6):899–904.CrossRefPubMed Pharand C, Ackman ML, Jackevicius CA, Paradiso-Hardy FL, Pearson GJ. Use of OTC and herbal products in patients with cardiovascular disease. Ann Pharmacother. 2003;37(6):899–904.CrossRefPubMed
8.
go back to reference Dal Corso E, Bondiani AL, Zanolla L, Vassanelli C. Nurse educational activity on non-prescription therapies in patients with chronic heart failure. Eur J Cardiovasc Nurs. 2007;6(4):314–20.CrossRefPubMed Dal Corso E, Bondiani AL, Zanolla L, Vassanelli C. Nurse educational activity on non-prescription therapies in patients with chronic heart failure. Eur J Cardiovasc Nurs. 2007;6(4):314–20.CrossRefPubMed
9.
go back to reference Gardiner P, Graham RE, Legedza AT, Eisenberg DM, Phillips RS. Factors associated with dietary supplement use among prescription medication users. Arch Intern Med. 2006;166(18):1968–74.CrossRefPubMed Gardiner P, Graham RE, Legedza AT, Eisenberg DM, Phillips RS. Factors associated with dietary supplement use among prescription medication users. Arch Intern Med. 2006;166(18):1968–74.CrossRefPubMed
10.
go back to reference Hensrud DD, Engle DD, Scheitel SM. Underreporting the use of dietary supplements and nonprescription medications among patients undergoing a periodic health examination. Mayo Clin Proc. 1999;74(5):443–7.CrossRefPubMed Hensrud DD, Engle DD, Scheitel SM. Underreporting the use of dietary supplements and nonprescription medications among patients undergoing a periodic health examination. Mayo Clin Proc. 1999;74(5):443–7.CrossRefPubMed
11.
go back to reference Kabbara WK, Dimassi H, Sheikh-Taha M. Patterns of pain medication use in older individuals with cardiovascular disease. Curr Med Res Opin. 2018;34(5):931–4.CrossRefPubMed Kabbara WK, Dimassi H, Sheikh-Taha M. Patterns of pain medication use in older individuals with cardiovascular disease. Curr Med Res Opin. 2018;34(5):931–4.CrossRefPubMed
12.
go back to reference Goh LY, Vitry AI, Semple SJ, Esterman A, Luszcz MA. Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly population. BMC Complement Altern Med. 2009;9(1):42.CrossRefPubMedPubMedCentral Goh LY, Vitry AI, Semple SJ, Esterman A, Luszcz MA. Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly population. BMC Complement Altern Med. 2009;9(1):42.CrossRefPubMedPubMedCentral
13.
go back to reference Stys T, Stys A, Kelly P, Lawson W. Trends in use of herbal and nutritional supplements in cardiovascular patients. Clin Cardiol. 2004;27(2):87–90.CrossRefPubMed Stys T, Stys A, Kelly P, Lawson W. Trends in use of herbal and nutritional supplements in cardiovascular patients. Clin Cardiol. 2004;27(2):87–90.CrossRefPubMed
14.
go back to reference Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867–78.CrossRefPubMedPubMedCentral Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867–78.CrossRefPubMedPubMedCentral
15.
go back to reference Alherbish A, Charrois TL, Ackman ML, Tsuyuki RT, Ezekowitz JA. The prevalence of natural health product use in patients with acute cardiovascular disease. PLoS One. 2011;6(5):e19623.CrossRefPubMedPubMedCentral Alherbish A, Charrois TL, Ackman ML, Tsuyuki RT, Ezekowitz JA. The prevalence of natural health product use in patients with acute cardiovascular disease. PLoS One. 2011;6(5):e19623.CrossRefPubMedPubMedCentral
16.
17.
go back to reference Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008;299(17):2027–36.CrossRefPubMedPubMedCentral Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008;299(17):2027–36.CrossRefPubMedPubMedCentral
18.
go back to reference Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' health study II randomized controlled trial. JAMA. 2008;300(18):2123–33.CrossRefPubMedPubMedCentral Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' health study II randomized controlled trial. JAMA. 2008;300(18):2123–33.CrossRefPubMedPubMedCentral
19.
go back to reference Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361(9374):2017–23.CrossRefPubMed Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361(9374):2017–23.CrossRefPubMed
20.
go back to reference Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S. Effects of a combination of beta carotene and vitamin a on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150–5.CrossRefPubMed Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S. Effects of a combination of beta carotene and vitamin a on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150–5.CrossRefPubMed
22.
go back to reference Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174–80.CrossRefPubMedPubMedCentral Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174–80.CrossRefPubMedPubMedCentral
23.
go back to reference Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503–11.CrossRefPubMed Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503–11.CrossRefPubMed
24.
go back to reference Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340–9.CrossRefPubMed Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340–9.CrossRefPubMed
25.
go back to reference Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106(7):963–8.CrossRefPubMed Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106(7):963–8.CrossRefPubMed
26.
go back to reference Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W, Vitamin D. cardiovascular disease prevention. Nat Rev Cardiol. 2016;13(7):404–17.CrossRefPubMed Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W, Vitamin D. cardiovascular disease prevention. Nat Rev Cardiol. 2016;13(7):404–17.CrossRefPubMed
27.
go back to reference Al Mheid I, Quyyumi AA. Vitamin D and cardiovascular disease: controversy unresolved. J Am Coll Cardiol. 2017;70(1):89–100.CrossRefPubMed Al Mheid I, Quyyumi AA. Vitamin D and cardiovascular disease: controversy unresolved. J Am Coll Cardiol. 2017;70(1):89–100.CrossRefPubMed
28.
go back to reference Singh S, Rao SS. Pharmacologic management of chronic constipation. Gastroenterol Clin N Am. 2010;39:509–27.CrossRef Singh S, Rao SS. Pharmacologic management of chronic constipation. Gastroenterol Clin N Am. 2010;39:509–27.CrossRef
29.
go back to reference DiPalma JA, vB Cleveland M, McGowan J, Herrera JL. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol. 2007;102(7):1436–41.CrossRefPubMed DiPalma JA, vB Cleveland M, McGowan J, Herrera JL. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol. 2007;102(7):1436–41.CrossRefPubMed
30.
go back to reference Corazziari E, Badiali D, Bazzocchi G, Bassotti G, Roselli P, Mastropaolo G, Lucà MG, Galeazzi R, Peruzzi E. Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut. 2000;46(4):522–6.CrossRefPubMedPubMedCentral Corazziari E, Badiali D, Bazzocchi G, Bassotti G, Roselli P, Mastropaolo G, Lucà MG, Galeazzi R, Peruzzi E. Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut. 2000;46(4):522–6.CrossRefPubMedPubMedCentral
31.
go back to reference By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Beers criteria update expert panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.CrossRef By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Beers criteria update expert panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.CrossRef
32.
go back to reference Bueno H, Bardají A, Patrignani P, Martín-Merino E, García-Rodríguez LA. Use of non steroidal anti-inflammatory drugs and type specific risk of acute coronary syndrome. Am J Cardiol. 2010;105:1102–6.CrossRefPubMed Bueno H, Bardají A, Patrignani P, Martín-Merino E, García-Rodríguez LA. Use of non steroidal anti-inflammatory drugs and type specific risk of acute coronary syndrome. Am J Cardiol. 2010;105:1102–6.CrossRefPubMed
33.
go back to reference Fanelli A, Ghisi D, Aprile PL, Lapi F. Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications. Ther Adv Drug Saf. 2017;8(6):173–82.CrossRefPubMedPubMedCentral Fanelli A, Ghisi D, Aprile PL, Lapi F. Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications. Ther Adv Drug Saf. 2017;8(6):173–82.CrossRefPubMedPubMedCentral
34.
go back to reference Loya AM, González-Stuart A, Rivera JO. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border. Drugs & Aging. 2009;26(5):423–36.CrossRef Loya AM, González-Stuart A, Rivera JO. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border. Drugs & Aging. 2009;26(5):423–36.CrossRef
Metadata
Title
Use of over the counter products in older cardiovascular patients admitted to a tertiary care center in USA
Authors
Marwan Sheikh-Taha
Hani Dimassi
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2018
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-018-0989-7

Other articles of this Issue 1/2018

BMC Geriatrics 1/2018 Go to the issue